Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

LENSAR, Inc. - Common Stock (NQ:LNSR)

14.06 -0.06 (-0.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about LENSAR, Inc. - Common Stock

< Previous 1 2 3 4 Next >
LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU
From LENSAR, Inc.
Via Business Wire
LENSAR Earnings Perspective: Return On Capital Employed
LENSAR (NASDAQ:LNSR) brought in sales totaling $8.04 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 1.27%, resulting in a loss of $6.76 million. 
Via Benzinga
First Patients Treated with LENSAR’s® ALLY™ Adaptive Cataract Treatment System
From LENSAR, Inc.
Via Business Wire
LENSAR: Q2 Earnings Insights
  LENSAR (NASDAQ:LNSR) reported its Q2 earnings results on Monday, August 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
Why Lensar Shares Are Trading Higher Today
Via Benzinga
Recap: LENSAR Q1 Earnings
LENSAR (NASDAQ:LNSR) reported its Q1 earnings results on Monday, May 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Outlook For LENSAR
LENSAR (NASDAQ:LNSR) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement. Analysts estimate that LENSAR will report an... 
Via Benzinga
LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022
From LENSAR, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System
From LENSAR, Inc.
Via Business Wire
LENSAR: Q4 Earnings Insights
LENSAR (NASDAQ:LNSR) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings LENSAR... 
Via Benzinga
Earnings Outlook For LENSAR
LENSAR (NASDAQ:LNSR) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
LENSAR's Return On Capital Employed Overview
LENSAR (NASDAQ:LNSR) brought in sales totaling $9.34 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 71.04%, resulting in a loss of $6.67 million. 
Via Benzinga
LENSAR Reports First Quarter 2022 Financial Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR Earnings Preview
LENSAR (NASDAQ:LNSR) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that LENSAR will report an... 
Via Benzinga
LENSAR Q1 2022 Earnings Conference Call On May 9, 2022 At 08:30 AM ET
LENSAR (NASDAQ:LNSR) will host a conference call at 08:30 AM ET on May 9, 2022, to discuss Q1 2022 earnings results. How to Attend LENSAR (LNSR) Conference Call Follow this link to access the live... 
Via Benzinga
LENSAR to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
From LENSAR, Inc.
Via Business Wire
Earnings Scheduled For May 9, 2022
Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million. 
Via Benzinga
LENSAR's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q4, LENSAR's (NASDAQ:LNSR) reported sales totaled $11.22 million. Despite a 36.6% increase in earnings, the company posted a loss of $3... 
Via Benzinga
LENSAR to Participate in Two Upcoming Investor Conferences
From LENSAR, Inc.
Via Business Wire
LENSAR to Present at the H.C. Wainwright Virtual BioConnect Conference
From LENSAR, Inc.
Via Business Wire
LENSAR to Present at Two Upcoming Investor Conferences
From LENSAR, Inc.
Via Business Wire
LENSAR Announces Poster Presentations at the American Academy of Ophthalmology
From LENSAR, Inc.
Via Business Wire
Earnings Scheduled For March 3, 2022
Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 22, 2021
Upgrades According to Evercore ISI Group, the prior rating for Kimco Realty Corp (NYSE: 
Via Benzinga
LENSAR Reports Third Quarter 2021 Financial Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
Earnings Scheduled For November 8, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •... 
Via Benzinga
LENSAR to Report Third Quarter 2021 Financial Results on Monday, November 8, 2021
From LENSAR, Inc.
Via Business Wire
LENSAR to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
From LENSAR, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.